Senior insider sale
Chief Scientific Officer at VOYAGER THERAPEUTICS, INC. — senior position signals high conviction
$38.8K
5.23K shares
What this filing means
CARTER TODD ALFRED plans to sell 5.23K shares of VOYAGER THERAPEUTICS, INC. valued at approximately $38.8K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 2/21/2024ACC: 0001959173-24-001230
Officer· Chief Scientific Officer
Since Feb 2026
5.23K
Shares to sell
$38.8K
Approx. market value
3.37K
Acquired (3 months)
1
Planned
2 completed
Securities Acquired — Last 3 Months1
Restricted Stock Vesting
Compensation
2/16/2024
3.37KTotal acquired3.37K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
2/16/2024 | Restricted Stock Vesting Compensation | 3.37K | — |
| Total | 3.37K | ||
Planned & Completed Dispositions3
Completed
—Completed
Units to sell
602.00
Market value
$4.6K
2/20/2024
—Completed
Units to sell
1.27K
Market value
$9.1K
1/17/2024
Planned — Approximate Date
NASDAQPlanned
Units to sell
3.37K
Market value
$25.1K
2/21/2024
Total
Units
5.23K
Value
$38.8K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
2/20/2024 | 602.00 | $4.6K | — | Completed |
1/17/2024 | 1.27K | $9.1K | — | Completed |
| Planned — Approximate Date | ||||
2/21/2024 | 3.37K | $25.1K | NASDAQ | Planned |
| Total | 5.23K | $38.8K | ||